This page includes the latest FDA filings for Iovance Biotherapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | IOVA | DUNS 962508433 |
Device Company | Device | Date |
---|---|---|
Iovance Biotherapeutics, Inc, Boehringer Ingelheim Pharma GmbH and Co. KG | Prescription Medication | 2024-12-22 |
Iovance Biotherapeutics Inc., Iovance Biotherpeutics Manufacturing, LLC, WuXi Advanced Therapies, Inc. | Other Medication | 2024-10-23 |
Iovance Biotherapeutics Inc., Iovance Biotherpeutics Manufacturing, LLC, WuXi Advanced Therapies, Inc. | Other Medication | 2024-03-02 |
Iovance Biotherapeutics, Inc, Boehringer Ingelheim Pharma GmbH and Co. KG | Prescription Medication | 2024-02-08 |
Iovance Biotherapeutics, Inc, Boehringer Ingelheim Pharma GmbH and Co. KG | Prescription Medication | 2024-02-07 |
SEC | 0001425205 | IOVANCE BIOTHERAPEUTICS, INC. of DELAWARE |